您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (2): 88-94.doi: 10.6040/j.issn.1671-7554.0.2022.0528

• 临床医学 • 上一篇    下一篇

细胞外容积分数对62例不同病理类型肺癌的诊断价值

杨咏青1,2,赵鹏2,汪玉1,马文静2,田迷迷1,程亚旎1,祖璐1,林祥涛1,2   

  1. 1.山东大学医学融合与实践中心, 山东 济南 250012;2.山东省立医院影像科, 山东 济南 250021
  • 发布日期:2023-02-17
  • 通讯作者: 林祥涛. E-mail:linxt616@163.com
  • 基金资助:
    山东省自然基金面上项目(ZR2021MH216)

Diagnostic value of extracellular volume fraction in 62 cases of different pathological types of lung cancer

YANG Yongqing1,2, ZHAO Peng2, WANG Yu1, MA Wenjing2, TIAN Mimi1, CHENG Yani1, ZU Lu1, LIN Xiangtao1,2   

  1. 1. Medical Integration and Practice Center of Shandong University, Jinan 250012, Shandong, China;
    2. Department of Radiology, Shandong Provincial Hospital, Jinan 250021, Shandong, China
  • Published:2023-02-17

PDF (PC)

251

摘要： 目的 探讨细胞外容积分数(ECV)对不同病理类型肺癌的诊断价值。 方法 对62例肺癌患者进行纵向弛豫时间定量(T1 mapping)扫描,在增强前后的T1 mapping图像上勾画感兴趣区,测量病灶、主动脉血池强化前后的T1值,收集患者的红细胞压积,计算ECV;运用单因素方差分析检验不同病理类型肺癌ECV的差异,构建受试者工作特征曲线分析其诊断价值,并计算灵敏度、特异度及准确率。 结果 共纳入62例患者,其中小细胞肺癌13例,非小细胞肺癌49例(包括33例腺癌、16例鳞癌)。小细胞肺癌与非小细胞肺癌的ECV平均值分别为(13.79±5.93)%和(27.17±6.59)%,非小细胞肺癌高于小细胞肺癌,截断值为18.97%,敏感度、特异度及准确率分别为89.8%、92.3%、90.3%;腺癌及鳞癌的ECV平均值分别为(24.21±4.92)%、(33.28±5.32)%,差异有统计学意义(P<0.001);鳞癌ECV值高于腺癌,截断值为29.11%,敏感度、特异度及准确率分别为84.8%、81.2%、83.7%。 结论 ECV可以定量分析肺癌的组织特征,可以通过测量ECV鉴别肺癌的病理类型,具有较高的灵敏度、特异度及准确率。

关键词: 细胞外容积分数, 肺癌, 病理类型, T1 mapping, 磁共振成像

Abstract: Objective To evaluate the differential diagnostic value of extracellular volume fraction(ECV)in the different pathological types of lung cancer. Methods Sixty-two patients with lung cancer were performed T1 mapping sequence in this prospective study. Areas of interest were delineated on T1 mapping images. The T1 value of lesions and aortic blood pool were measured in the T1 mapping images before and after enhancement. Hematocrit was collected to calculate the ECV. One-way ANOVA was used to compare the differences among the different pathological types of lung cancer. The receiver operating characteristic curve was constructed to analyze its diagnostic value. The sensitivity,specificity and accuracy were calculated. Results A total of 62 patients were included, including 13 cases of small cell lung cancer and 49 cases of non-small cell lung cancer(including 33 cases of adenocarcinoma and 16 cases of squamous cell carcinoma). The mean ECV of small cell lung cancer and non-small cell lung cancer were(13.79±5.93)% and(27.17±6.59)%, respectively. The ECV value of non-small cell lung cancer was higher than small cell lung cancer, and the cut-off value was 18.97%. The sensitivity, specificity and accuracy were 89.8%, 92.3%, and 90.3%, respectively. The average ECV values of adenocarcinoma and squamous cell carcinoma were(24.21±4.92)% and(33.28±5.32)%, respectively, and the difference was statistically significant(P<0.001). The ECV value of carcinoma was higher than adenocarcinoma, the cut-off value was 29.11%, and the sensitivity, specificity and accuracy were 84.8%, 81.2% and 83.7%, respectively. Conclusion ECV can quantitatively analyze the tissue characteristics of lung cancer, and identify the pathological type of lung cancer, with good sensitivity, specificity and accuracy.

Key words: Extracellular volume, Lung cancer, Pathological results, T1 mapping, Magnetic resonance imaging

中图分类号: 

  • R445.2
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2] 邹红烨,左敏静. 双能量CT在肺癌中的应用进展[J]. 放射学实践,2021, 36(1): 133-136.
[3] 李明英,王广丽,崔丁也,等. 能谱CT成像对肺癌分型的初步研究[J]. 山东大学学报(医学版), 2012, 50(12): 73-76. LI Mingying, WANG Guangli, CUI Dingye, et al. Preliminary study of lung cancer types with gemstone spectral CT imaging[J]. Journal of Shandong University(Health Science), 2012, 50(12): 73-76.
[4] Kauczor HU. MRI of the lung[M]. Berlin Heidelberg: Springer-Verlag, 2009: 3-16, 179-216.
[5] 崔凤娇,罗娅红. 基于影像学的腹部病变细胞外容积的研究进展[J]. 放射学实践, 2020, 35(9): 1196-1198.
[6] 殷亮,喻思思,龚良庚.心脏磁共振纵向弛豫时间定量成像技术进展[J].中华放射学杂志, 2016, 50(1): 76-78.
[7] 王宝,刘英超,赵斌,等. 强化T1 mapping技术在鉴别脑转移瘤伽马刀治疗后复发和放射性坏死中的价值[J]. 中华放射学杂志, 2019, 53(6): 447-452. WANG Bao, LIU Yingchao, ZHAO Bin, et al. The value of contrast enhanced T1 mapping technique in differentiating recurrence and radiation necrosis of brain metastases after gamma knife treatment[J]. Chinese Journal of Radiology, 2019, 53(6): 447-452.
[8] Shah B, Anderson SW, Scalera J, et al. Quantitative MR imaging: physical principles and sequence design in abdominal imaging[J]. Radiographics, 2011, 31(3): 867-880.
[9] Yang S, Shan F, Yan Q, et al. A pilot study of native T1-mapping for focal pulmonary lesions in 3.0 T magnetic resonance imaging: size estimation and differential diagnosis[J]. J Thorac Dis, 2020, 12(5): 2517-2528.
[10] Lee JJ, Liu S, Nacif MS, et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla [J]. J Cardiovasc Magn Reson, 2011, 3(1): 75. doi: 10.1186/1532-429X-13-75.
[11] 刘新峰,马海彦,王荣品,等. T1mapping和细胞外容积分数技术在急性病毒性心肌炎的临床应用[J]. 实用医学杂志, 2019, 35(5): 800-803, 808.
[12] Lee SW, Kwak HS, Kang MH, et al. Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid[J]. Sci Rep, 2018, 8(1): 2365. doi: 10.1038/S41598-018-20886-0.
[13] Robinson AA, Chow K, Salerno M. Myocardial T1 and ECV measurement: underlying concepts and technical considerations[J]. JACC Cardiovasc Imaging, 2019, 12(11 Pt 2): 2332-2344.
[14] Morita K, Nishie A, Ushijima Y, et al. Noninvasive assessment of liver fibrosis by dual-layer spectral detector CT[J]. Eur J Radiol, 2021, 136: 109575. doi: 10.1016/j.ejrad.2021.109575.
[15] Luetkens JA, Klein S, Träber F, et al. Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: preclinical results[J]. Radiology, 2018, 288(3): 748-754.
[16] Mason T, Coelho-Filho OR, Verma S, et al. Empagliflozin reduces myocardial extracellular volume in patients with type 2 diabetes and coronary artery disease[J]. JACC Cardiovasc Imaging, 2021, 14(6): 1164-1173.
[17] Kitkungvan D, Yang EY, El Tallawi KC, et al. Extracellular volume in primary mitral regurgitation[J]. JACC Cardiovasc Imaging, 2021, 14(6): 1146-1160.
[18] Kameda F, Tanabe M, Higashi M, et al. The extracellular volume fraction of the pancreas measured by dual-energy computed tomography: the association with impaired glucose tolerance[J]. Eur J Radiol, 2021, 141: 109775. doi: 10.1016/j.ejrad.2021.109775.
[19] Campbell-Washburn AE, Price AN, Ellmerich S, et al. Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction[J]. Amyloid, 2013, 20(2): 93-98.
[20] Adams LC, Jurmeister P, Ralla B, et al. Assessment of the extracellular volume fraction for the grading of clear cell renal cell carcinoma: first results and histopathological findings[J]. Eur Radiol, 2019, 29(11): 5832-5843.
[21] Fukukura Y, Kumagae Y, Higashi R, et al. Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy[J]. Eur Radiol, 2019, 29(1): 353-361.
[22] 崔凤娇,李琳,罗娅红,等. 应用细胞外体积分数评估肝细胞癌分化程度的初步探索[J]. 肿瘤影像学, 2020, 29(3): 303-307.
[23] Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification[J]. Arch Pathol Lab Med, 2013, 137(5): 668-684.
[24] 冯会,时高峰,刘辉,等. 自由呼吸Star-VIBE序列动态增强MRI联合DWI在孤立性肺结节诊断中的应用[J]. 放射学实践, 2020, 35(7): 855-859. FENG Hui, SHI Gaofeng, LIU Hui, et al. The application of free-breathing star-VIBE sequence dynamic enhanced MRI combined with DWI in the diagnosis of solitary pulmonary nodules[J]. Radiologic Practice, 2020, 35(7): 855-859.
[25] 库雷志,马明平,俞顺,等. DCE-MRI在肺癌不同病理类型的诊断价值[J]. 中国医学影像学杂志, 2016, 24(2): 100-105. KU Leizhi, MA Mingping, YU Shun, et al. Dynamic contrast-enhanced MRI in diagnosis of different histopathological types of lung carcinoma[J]. Chinese Journal of Medical Imaging, 2016, 24(2): 100-105.
[26] 脱朝伟,吴泽全,张宁,等. 肺癌的电镜诊断及分类[J]. 中国医学影像技术, 2002, 18(5): 485. doi: 10.13929/j.1003-3289.2002.05.051.
[1] 黄佩文, 王旭东. 治疗非小细胞肺癌新药:靶向c-Met蛋白的抗体药物偶联物Telisotuzumab Vedotin[J]. 山东大学学报 (医学版), 2026, 64(3): 124-130.
[2] 金晨曦,沈薇,李娜,孙建锋,杨驰,郭泾. ADDWoR关节镜下盘复位术盘-髁运动的定量分析[J]. 山东大学学报 (医学版), 2025, 63(7): 54-61.
[3] 赵汉卿,周新睿,李子建,唐兴. 循环肿瘤细胞联合血清学检测在非小细胞肺癌中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 79-85.
[4] 徐年兴,魏东,乔俊杰,战炳炎. CD8+、IL-6和PaO2对不可切除ⅢB/C和Ⅳ期非小细胞肺癌免疫治疗触发放射召回性肺炎的预测价值[J]. 山东大学学报 (医学版), 2025, 63(2): 29-35.
[5] 山东省腔镜外科质量控制中心胸腔镜委员会. 山东省VATS/RATS非小细胞肺癌围术期质量控制指标专家共识(2025版)[J]. 山东大学学报 (医学版), 2025, 63(12): 1-5.
[6] 李懿原,马珊,李爱华,龙飞. 超声支气管镜引导下碘-125粒子植入治疗肺癌中央区淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(12): 26-34.
[7] 刘振昆,吕纪玲,徐伟伟,马力天,张才擎. BALF tNGS检测及培养对NSCLC合并IPFD的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(11): 36-45.
[8] 刘晶晶,庞婧,赵晓丹,林昕,付敏,陈静静. 基于乳腺X线摄影及DCE-MRI机器学习模型预测乳腺癌新辅助治疗后病理完全缓解:双中心研究[J]. 山东大学学报 (医学版), 2025, 63(1): 60-72.
[9] 张荣雨,赵文,李洪欣,杨闯,王健,韩春燕,李际盛. 奥西替尼联合化疗一线治疗EGFR-RAD51融合突变转移性肺腺癌1例[J]. 山东大学学报 (医学版), 2024, 62(5): 116-120.
[10] 刘小文,曹永泉,侯明源,于德新. EOB-MRI多定量参数对肝胆期乏血供低信号结节进展风险的评估价值[J]. 山东大学学报 (医学版), 2024, 62(4): 31-39.
[11] 吴思雨,沈业隆,王锡明. 影像组学预测原发性中枢神经系统淋巴瘤的Ki-67标记指数[J]. 山东大学学报 (医学版), 2024, 62(11): 67-72.
[12] 王亚楠,梁传杰,贾梦琪,苑辉卿. 二硫键异构酶TMX1促进肺癌化疗耐药[J]. 山东大学学报 (医学版), 2023, 61(8): 31-39.
[13] 王蕾,向淇,刘学伍. 伴系统性硬化症、类风湿关节炎的副肿瘤神经综合征1例[J]. 山东大学学报 (医学版), 2023, 61(7): 118-120.
[14] 靳新娟,左立平,邓展昊,李安宁,于德新. MRI影像组学对135例肝癌耐药蛋白PFKFB3的预测价值[J]. 山东大学学报 (医学版), 2023, 61(6): 79-86.
[15] 钟璐,薛付忠. 基于贝叶斯网络不确定性推理的肺癌风险预测模型[J]. 山东大学学报 (医学版), 2023, 61(4): 86-94.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发